Is the Dissection of the Level IV Lymph Node Pads Necessary in the Elective Lateral Neck Dissection of N0 Supraglottic Squamous Cell Carcinoma?.
- Author:
Young Chang LIM
1
;
Min Bum KIM
;
Hyang Ae SHIN
;
Soon Ho KWON
;
Sei Young LEE
;
Jin Seok LEE
;
Bon Seok KOO
;
Eun Chang CHOI
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Konkuk University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Laryngeal neoplasm;
Squamous cell carcinoma;
Neck dissection
- MeSH:
Carcinoma, Squamous Cell*;
Humans;
Incidence;
Laryngeal Neoplasms;
Larynx;
Lymph Nodes*;
Neck Dissection*;
Neck*;
Neoplasm Metastasis;
Prospective Studies;
Recurrence
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2005;48(9):1131-1135
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: To determine whether level IV lymph nodes can be saved in the elective lateral neck dissection (LND) as a treatment for patients with squamous cell carcinoma of the supraglottic larynx. SUBJECTS AND METHODS: From January 1997 to May 2002, 42 patients with supraglottic squamous cell carcinoma and a clinically N0 neck who underwent an elective LND were studied prospectively. The incidence of pathological metastasis to the level IV lymph nodes and a regional recurrence after an elective LND were evaluated. RESULTS: Of the 42 patients, 10 (24%) had lymph nodes positive for microscopic metastatic squamous cell carcinoma. Two (5%) of the 42 patients had involvement of the level IV lymph nodes, whose clinical T-stages were above cT3. None of the clinical T1 or T2 tumors showed level IV nodal metastasis. There were two cases (5%) of the ipsilateral neck recurrence: these patients developed recurrence in the level II and stomal area, respectively. CONCLUSION: The level IV lymph node metastasis was rare in this study, and nodal recurrence after LND in squamous cell carcinoma of the supraglottic larynx was infrequent. Therefore, this region may be preserved in elective LND for patients with early squamous cell carcinoma of the supraglottic larynx.
